ClinConnect ClinConnect Logo
Search / Trial NCT06981065

The Scandinavian Displaced Lateral Clavicle Trial

Launched by UPPSALA UNIVERSITY · May 19, 2025

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

Displaced Lateral Clavicle Fracture Non Surgical Surgical Pro Ms Health Economy Non Inferior Complications

ClinConnect Summary

The Scandinavian Displaced Lateral Clavicle Trial is a research study looking into the best way to treat certain types of clavicle fractures, specifically those that are displaced and occur at the outer end of the collarbone. The trial will compare two treatment methods: one that involves surgery and another that relies on non-surgical care, to see if the non-surgical option is just as effective. This study is important because it could help doctors determine whether surgery is always necessary for this type of injury.

To be eligible for this trial, participants must be adults who have a specific type of clavicle fracture known as a type II or V fracture based on a classification system. Unfortunately, those with certain conditions—like open fractures, severe injuries, or who can't give consent—won't be able to participate. If you join the study, you can expect to receive either the surgical treatment or the non-surgical care, and you will be closely monitored throughout the process to see how well the treatments work. The trial is not yet recruiting participants, but it aims to gather important information that could improve care for patients with these types of fractures in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Displaced extraarticular lateral clavicle fracture (type II or V according to the modified Neer classification)
  • Exclusion Criteria:
  • Pathological fracture
  • Open fracture
  • Neurovascular injury
  • Same-time fracture in the upper extremity
  • Polytrauma
  • Contraindications to surgery and/or anesthesia
  • Unable to give informed consent
  • Inability to complete follow-up

About Uppsala University

Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.

Locations

Odense, , Denmark

Stockholm, , Sweden

Tampere, , Finland

Linköping, , Sweden

örebro, , Sweden

Umeå, , Sweden

Malmö, , Sweden

Uppsala, , Sweden

Fredrikstad, , Norway

Patients applied

0 patients applied

Trial Officials

Olof Wolf, Associate Professor, MD

Principal Investigator

Uppsala University Hospital and Uppsala University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported